2U3:FRA
Alcon AG
60,72 €
arrow_upward
+1,67%(+1,00) 1D
22. okt., 11:21:08 GMT +2 · EUR
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za 2U3 …
Odpri
59,26 €
Visoka
60,72 €
Nizka
59,26 €
Tržna kapitalizacija
28,84 mrd.
Povprečni promet
230,00
Promet
160,00
52-tedenski najvišji tečaj
73,96 €
52-tedenski najnižji tečaj
51,78 €
Št. zaposlenih
25 tis.
Odpri
59,26 €
Visoka
60,72 €
Nizka
59,26 €
Tržna kapitalizacija
28,84 mrd.
Povprečni promet
230,00
Promet
160,00
52-tedenski najvišji tečaj
73,96 €
52-tedenski najnižji tečaj
51,78 €
Št. zaposlenih
25 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
Yahoo Finance
·
pred 22 urami
Alcon's Neurotech Acquisition Offers Significant Growth Potential, Needham Says
Yahoo Finance
·
pred 1 dnevom
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Vizitka: Alcon AG
Generalni direktorDavid J. Endicott
Št. zaposlenih25 tis.
Ustanovljeno1945
SedežŽeneva, Ženeva, Švica
Sektor-
Spletno mestoalcon.com